Search Results 1861-1870 of 4062 for Solid
We hope that regenerative sciences will discover and perfect ways to expand this treatment approach to solid cancers, as well," says Dr. Terzic ...
Other completely resected stage 1 solid tumor with low risk for recurrence. Treatment with any prior gene therapy product. Subjects who have received ...
Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.
Measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria is required except for subjects with bone only disease. All prior ...
... solid tumor patients. A Study To Evaluate Oncologic Outcomes And Quality Of Life In Sinonasal Cancer Patients. Rochester, Minn. This is a multi-site study ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined ...
... Solid Tumors (RECIST); Prior or concurrent therapy with SSA is permitted; a stable dose at least 2 months prior to study start and must continue on the ...
Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!